A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis (Q78571623)
Jump to navigation
Jump to search
scientific article published on 01 December 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis |
scientific article published on 01 December 2002 |
Statements
A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis (English)
Gerald G Krueger
Dow B Stough
Keith H Loven
Wayne P Gulliver
Charles N Ellis
Alefacept Clinical Study Group
1 December 2002